7th Circuit: Quirk Preempts 1,000s Of Testosterone Cases Involving ‘Depo-T’

(January 23, 2018, 12:43 PM EST) -- CHICAGO — The Seventh Circuit U.S. Court of Appeals on Jan. 19 said a regulatory quirk in how the testosterone drug Depo-T is classified means that thousands of product liability claims...
To view the full article, register now.